HY Pharma is one of Chinese leading generic pharmaceutical companies focusing on manufacturing APIs and intermediates for antihyperlipidemia/anti-hypertensive drugs. With strict GMP production system, the quality of Atorvastatin, Rosuvastatin, Empaliflozin, Azilsartan and Dapagliflozin is recognized by worldwide top pharmaceutical companies. HY Pharma also offers customized manufacturing services to partners and recognized for its strengths in R&D and commercialization of a wide range of products.
more >
Year of Establishment:
2005
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
N;
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: